Rwanda steps up livestock vaccination and monitoring after its latest outbreak of Rift Valley Fever, which can spread to humans.

LONDON, Nov 12 (Reuters) - London-listed drugmaker AstraZeneca (AZN.L), opens new tab said its plan to invest 450 million ...

AstraZeneca’s new U.S. spending also leaves in doubt the pharmaceutical company’s plans to invest in a vaccine site in ...

Nov 12 (Reuters) - Novavax (NVAX.O), opens new tab cut its annual revenue forecast on Tuesday, citing lower-than-expected ...

London-listed drugmaker AstraZeneca said its plan to invest 450 million pounds ($576.7 million) in Britain for vaccine ...

Among AstraZeneca’s various therapeutic areas, Oncology product sales were up 22%, while Cardiovascular, Renal and Metabolism ...

The company said it aims to expand its U.S. presence by the end of 2026. The new spending will be for a research-and-development center in Cambridge, Mass.; manufacturing plants in Maryland and Texas, ...

AstraZeneca ( (AZN) ) has released its Q3 earnings. Here is a breakdown of the information AstraZeneca presented to its investors. AstraZeneca ...

This strategic move positions BioVaxys alongside major players like AstraZeneca and Genentech, enhancing its role in developing priority vaccine programs. For further insights into TSE:BIOV stock, ...

Kennedy, who ran for president as an independent this year before he dropped his bid and endorsed Trump, has long spread conspiracies and falsehoods about vaccines and other public health matters.

A new World Health Organization (WHO) study published today in eBioMedicine names 17 pathogens that regularly cause diseases in communities as top priorities for new vaccine development.